Background: In this Cross sectional study over a period of one year, conducted in the Division of Cardiology, Dept. of Medicine, Govt. Medical College Hospital Jammu, a total of 50 cases were studied for cardiovascular abnormalities occurring in thyrotoxicosis. Aims: We investigated the prevalence and clinical importance of cardiovascular abnormalities in patience with thyrotoxicosis. Settings and Design: This is a cross sectional study conducted over a period of one year in a tertiary care hospital offering specialty and super specialty including cardiology. We studied 50 cases of whom 11 were males and 39 were females. The study covered age group with a range of 16 years to 85 years. Methods and Material: All newly diagnosed cased of thyrotoxicosis were included in the study and were evaluated on a protocol which includes: history, general physical examination, cardiovascular examination and investigation: bio chemical profile, hormonal assay, chest radiography, twelve – lead electrocardiogram (ECG), Echocardiography (ECHO) (M-Mode/2 dimensional/Colour Doppler). Statistical Analysis: Descriptive analysis including calculation of percentages as deemed fit for qualitative variables. For quantitative variables, mean and standard deviation were calculated and reported. Results: 50 patients (Mean [+/- SD] age, 45.7 yrs, range 16-85 yrs; 78% females) were included. Weakness and fatigability was present in every patient (100%), followed by palpitation, shortness of breath and weight loss (94%). We found ventricular hypertrophy (40%), congestive heart failure (CHF) (36%), cardiomegaly (24%), arrhythmias (24%) and bundle branch block (18%) of the patients. Conclusion: Cardiovascular abnormalities in thyrotoxicosis should never be over looked, prognosis and outcome of the heart disease depends on early institution of treatment and control of the hormone levels. J MEDICINE July 2015; 16 (2) : 69-72
[1]
L. Papadaki,et al.
Cardiovascular effects of thyroxine.
,
1969,
Cardiovascular research.
[2]
J. Auer,et al.
Subclinical hyperthyroidism as a risk factor for atrial fibrillation.
,
2001,
American heart journal.
[3]
A. Bardají,et al.
Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study.
,
2005,
The American journal of medicine.
[4]
C. Symons.
Thyroid heart disease.
,
1979,
British heart journal.
[5]
S. Krishnamoorthy,et al.
Unusual presentation of thyrotoxicosis as complete heart block and renal failure: a case report
,
2009,
Journal of medical case reports.
[6]
G. Gordan,et al.
ELECTROCARDIOGRAPHIC FEATURES ASSOCIATED WITH HYPERTHYROIDISM
,
1944
.
[7]
I. Klein,et al.
Thyroid disease and the heart.
,
2007,
Circulation.
[8]
S. Bhadada,et al.
Juvenile hyperthyroidism: an experience.
,
2006,
Indian pediatrics.
[9]
A. Toft,et al.
CARDIOVASCULAR RESPONSES IN HYPERTHYROIDISM BEFORE AND DURING 0‐ADRENOCEPTOR BLOCKADE: EVIDENCE AGAINST ADRENERGIC HYPERSENSITIVITY
,
1982,
Clinical endocrinology.
[10]
C. Lau,et al.
Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism
,
2006,
Heart.